Annual D&A
$165.70 K
+$45.20 K+37.51%
December 1, 2023
Summary
- As of February 12, 2025, BRTX annual depreciation & amortization is $165.70 thousand, with the most recent change of +$45.20 thousand (+37.51%) on December 1, 2023.
- During the last 3 years, BRTX annual D&A has risen by +$44.30 thousand (+36.49%).
- BRTX annual D&A is now -36.10% below its all-time high of $259.30 thousand, reached on December 31, 2017.
Performance
BRTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$48.30 K
+$600.00+1.26%
September 1, 2024
Summary
- As of February 12, 2025, BRTX quarterly depreciation & amortization is $48.30 thousand, with the most recent change of +$600.00 (+1.26%) on September 1, 2024.
- Over the past year, BRTX quarterly D&A has increased by +$6200.00 (+14.73%).
- BRTX quarterly D&A is now -26.48% below its all-time high of $65.70 thousand, reached on December 31, 2016.
Performance
BRTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$181.40 K
+$6200.00+3.54%
September 1, 2024
Summary
- As of February 12, 2025, BRTX TTM depreciation & amortization is $181.40 thousand, with the most recent change of +$6200.00 (+3.54%) on September 1, 2024.
- Over the past year, BRTX TTM D&A has increased by +$26.60 thousand (+17.18%).
- BRTX TTM D&A is now -30.47% below its all-time high of $260.90 thousand, reached on September 30, 2017.
Performance
BRTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
BRTX Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +37.5% | +14.7% | +17.2% |
3 y3 years | +36.5% | +124.7% | +103.6% |
5 y5 years | -31.1% | +124.7% | +103.6% |
BRTX Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +86.0% | at high | +124.7% | at high | +103.6% |
5 y | 5-year | -23.8% | +86.0% | -13.6% | +124.7% | -16.6% | +103.6% |
alltime | all time | -36.1% | +242.4% | -26.5% | +368.9% | -30.5% | +631.5% |
BioRestorative Therapies Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $48.30 K(+1.3%) | $181.40 K(+3.5%) |
Jun 2024 | - | $47.70 K(+11.7%) | $175.20 K(+3.7%) |
Mar 2024 | - | $42.70 K(0.0%) | $169.00 K(+2.0%) |
Dec 2023 | $165.70 K(+37.5%) | $42.70 K(+1.4%) | $165.70 K(+7.0%) |
Sep 2023 | - | $42.10 K(+1.4%) | $154.80 K(+7.6%) |
Jun 2023 | - | $41.50 K(+5.3%) | $143.90 K(+7.5%) |
Mar 2023 | - | $39.40 K(+23.9%) | $133.90 K(+11.1%) |
Dec 2022 | $120.50 K(+35.2%) | $31.80 K(+1.9%) | $120.50 K(+9.3%) |
Sep 2022 | - | $31.20 K(-1.0%) | $110.20 K(+9.5%) |
Jun 2022 | - | $31.50 K(+21.2%) | $100.60 K(+10.7%) |
Mar 2022 | - | $26.00 K(+20.9%) | $90.90 K(+2.0%) |
Dec 2021 | $89.10 K(-26.6%) | $21.50 K(-0.5%) | $89.10 K(-4.3%) |
Sep 2021 | - | $21.60 K(-0.9%) | $93.10 K(-4.0%) |
Jun 2021 | - | $21.80 K(-9.9%) | $97.00 K(-4.8%) |
Mar 2021 | - | $24.20 K(-5.1%) | $101.90 K(-16.1%) |
Dec 2020 | $121.40 K(-44.2%) | $25.50 K(0.0%) | $121.50 K(-20.0%) |
Sep 2020 | - | $25.50 K(-4.5%) | $151.90 K(-16.6%) |
Jun 2020 | - | $26.70 K(-39.0%) | $182.20 K(-12.6%) |
Mar 2020 | - | $43.80 K(-21.6%) | $208.50 K(-4.1%) |
Dec 2019 | $217.40 K(-9.6%) | $55.90 K(+0.2%) | $217.40 K(-0.6%) |
Sep 2019 | - | $55.80 K(+5.3%) | $218.80 K(-2.5%) |
Jun 2019 | - | $53.00 K(+0.6%) | $224.40 K(-3.4%) |
Mar 2019 | - | $52.70 K(-8.0%) | $232.40 K(-3.3%) |
Dec 2018 | $240.40 K(-7.3%) | $57.30 K(-6.7%) | $240.30 K(-2.8%) |
Sep 2018 | - | $61.40 K(+0.7%) | $247.10 K(-1.7%) |
Jun 2018 | - | $61.00 K(+0.7%) | $251.40 K(-1.6%) |
Mar 2018 | - | $60.60 K(-5.5%) | $255.60 K(-1.4%) |
Dec 2017 | $259.30 K | $64.10 K(-2.4%) | $259.30 K(-0.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2017 | - | $65.70 K(+0.8%) | $260.90 K(+0.1%) |
Jun 2017 | - | $65.20 K(+1.4%) | $260.70 K(+0.2%) |
Mar 2017 | - | $64.30 K(-2.1%) | $260.30 K(+0.7%) |
Dec 2016 | $258.40 K(+20.9%) | $65.70 K(+0.3%) | $258.40 K(+1.0%) |
Sep 2016 | - | $65.50 K(+1.1%) | $255.80 K(+1.7%) |
Jun 2016 | - | $64.80 K(+3.8%) | $251.50 K(+6.3%) |
Mar 2016 | - | $62.40 K(-1.1%) | $236.50 K(+10.7%) |
Dec 2015 | $213.80 K(+121.1%) | $63.10 K(+3.1%) | $213.70 K(+23.2%) |
Sep 2015 | - | $61.20 K(+22.9%) | $173.40 K(+27.5%) |
Jun 2015 | - | $49.80 K(+25.8%) | $136.00 K(+22.7%) |
Mar 2015 | - | $39.60 K(+73.7%) | $110.80 K(+14.6%) |
Dec 2014 | $96.70 K(-7.7%) | $22.80 K(-4.2%) | $96.70 K(-2.9%) |
Sep 2014 | - | $23.80 K(-3.3%) | $99.60 K(-2.2%) |
Jun 2014 | - | $24.60 K(-3.5%) | $101.80 K(-1.7%) |
Mar 2014 | - | $25.50 K(-0.8%) | $103.60 K(-1.1%) |
Dec 2013 | $104.80 K(+15.9%) | $25.70 K(-1.2%) | $104.80 K(-1.2%) |
Sep 2013 | - | $26.00 K(-1.5%) | $106.10 K(-0.9%) |
Jun 2013 | - | $26.40 K(-1.1%) | $107.10 K(+17.7%) |
Mar 2013 | - | $26.70 K(-1.1%) | $91.00 K(+0.8%) |
Dec 2012 | $90.40 K(0.0%) | $27.00 K(0.0%) | $90.30 K(+18.8%) |
Sep 2012 | - | $27.00 K(+162.1%) | $76.00 K(+2.3%) |
Jun 2012 | - | $10.30 K(-60.4%) | $74.30 K(-18.9%) |
Mar 2012 | - | $26.00 K(+104.7%) | $91.60 K(+1.3%) |
Dec 2011 | $90.40 K(+86.8%) | $12.70 K(-49.8%) | $90.40 K(+16.3%) |
Sep 2011 | - | $25.30 K(-8.3%) | $77.70 K(+48.3%) |
Jun 2011 | - | $27.60 K(+11.3%) | $52.40 K(+111.3%) |
Mar 2011 | - | $24.80 K | $24.80 K |
Dec 2010 | $48.40 K | - | - |
FAQ
- What is BioRestorative Therapies annual depreciation & amortization?
- What is the all time high annual D&A for BioRestorative Therapies?
- What is BioRestorative Therapies annual D&A year-on-year change?
- What is BioRestorative Therapies quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioRestorative Therapies?
- What is BioRestorative Therapies quarterly D&A year-on-year change?
- What is BioRestorative Therapies TTM depreciation & amortization?
- What is the all time high TTM D&A for BioRestorative Therapies?
- What is BioRestorative Therapies TTM D&A year-on-year change?
What is BioRestorative Therapies annual depreciation & amortization?
The current annual D&A of BRTX is $165.70 K
What is the all time high annual D&A for BioRestorative Therapies?
BioRestorative Therapies all-time high annual depreciation & amortization is $259.30 K
What is BioRestorative Therapies annual D&A year-on-year change?
Over the past year, BRTX annual depreciation & amortization has changed by +$45.20 K (+37.51%)
What is BioRestorative Therapies quarterly depreciation & amortization?
The current quarterly D&A of BRTX is $48.30 K
What is the all time high quarterly D&A for BioRestorative Therapies?
BioRestorative Therapies all-time high quarterly depreciation & amortization is $65.70 K
What is BioRestorative Therapies quarterly D&A year-on-year change?
Over the past year, BRTX quarterly depreciation & amortization has changed by +$6200.00 (+14.73%)
What is BioRestorative Therapies TTM depreciation & amortization?
The current TTM D&A of BRTX is $181.40 K
What is the all time high TTM D&A for BioRestorative Therapies?
BioRestorative Therapies all-time high TTM depreciation & amortization is $260.90 K
What is BioRestorative Therapies TTM D&A year-on-year change?
Over the past year, BRTX TTM depreciation & amortization has changed by +$26.60 K (+17.18%)